Contact: Paul Davis,
DFA Drug Affordability Campaign Director
(202) 817-0129 / email@example.com
The House of Representatives is set to vote Thursday on H.R. 3, the Elijah Cummings Lower Drug Costs Now Act. Doctors for America (DFA), which represents more than 21,000 doctors and medical students nationwide, urges both the House and Senate to pass this bill as soon as possible. The group strongly supports H.R. 3 and urges Congress to continue to push for additional legislation that gets affordable medicine to everyone, everywhere, whether they have insurance or not.
“H.R. 3 is a laudable down-payment towards reigning in excessive prices. It is a much-needed step towards ensuring that many of my patients no longer face the too-frequent reality of rationing food or medicine,” said Dr. Reshma Ramachandran, a family medicine resident and a member of DFA’s Drug Affordability Steering Committee. “We are grateful for the recent improvements made to the bill by the Progressive Caucus that increase the minimum number of drugs that must be negotiated, and that extend price spike protections to many more of our patients.”
DFA appreciates Representative Lloyd Doggett and his staff for their long-time leadership on this issue, as well as Representatives Pocan and Jayapal for leveraging progressive energy into improved outcomes. Leader Pelosi and her staff should also be applauded for marshaling this bill to the floor in spite of enormous opposition from prescription drug corporations.
Doctors for America mobilizes doctors and medical trainees in all 50 states and calls for policymakers to recognize and guarantee access to truly affordable medicine as a right. DFA advocates for lasting solutions to high pharmaceutical prices, which will require the government to tackle drug company abuses of the monopoly system.